Concepedia

Stephen Inglis

SI

Statistics

Publications

46

Citations

7.4K

H-Index

38

Active since

1976

Affiliations

University of Cambridge(Current)

Addenbrooke's Hospital

Speechmatics (United Kingdom)

University of Sheffield

Napp Pharmaceuticals (United Kingdom)

Stephen Inglis is an author at University of Cambridge specializing in virology, molecular virology, and life sciences.

Publications per year

1976–2021

46

Publications

46

SARS-CoV-2 evolution during treatment of chronic infection

Steven A. Kemp, Dami A. Collier, Rawlings Datir et al. · Nature · 2021 · 1.1K citations · Full text

, , +14

Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies

Dami A. Collier, Anna De Marco, Isabella A.T.M. Ferreira et al. · Nature · 2021 · 716 citations · Full text

, , +14

Characterization of an efficient coronavirus ribosomal frameshifting signal: Requirement for an RNA pseudoknot

Ian Brierley, Paul Digard, Stephen Inglis · Cell · 1989 · 697 citations · Full text

, , +14

A recombinant vaccinia virus encoding human papillomavirus types 16 and 18, E6 and E7 proteins as immunotherapy for cervical cancer

Leszek K. Borysiewicz, Alison Fiander, M. Nimako et al. · The Lancet · 1996 · 530 citations

, , +15

Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7

Bo Meng, Steven A. Kemp, Guido Papa et al. · Cell Reports · 2021 · 452 citations · Full text

, , +17

1–5 of 46